Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Ewart Toland

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Familial Cancer|April 15, 2024
Clinical features of prostate cancer by polygenic risk scoreChristina Spears, Menglin Xu, Abigail Shoben, et al.
Cancer Research|January 28, 2010
Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombinationDerek J R Ransburgh, Natsuko Chiba, Chikashi Ishioka, et al.
Familial Cancer|April 3, 2009
Methylation not a frequent "second hit" in tumors with germline BRCA mutationsAmy M Dworkin, Andrew D Spearman, Stephanie Y Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceAndrew D Spearman, Kevin Sweet, Xiao-Ping Zhou, et al.
Journal of Genetic Counseling|March 8, 2019
Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM)Christopher Heinlen, Shelly R Hovick, Guy N Brock, et al.
Acta Neurochirurgica|January 4, 2022
Genetic analysis of a malignant meningioma and associated metastasesKristin Huntoon, Ayse Selen Yilmaz, Maciej Pietrzak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2014
Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcomaJessica A Hemminger, Amanda Ewart Toland, Thomas J Scharschmidt, et al.
Peerj|May 7, 2013
Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible miceJessica L Fleming, Dustin L Gable, Somayeh Samadzadeh-Tarighat, et al.
Genes, Chromosomes & Cancer|March 20, 2009
Chromosomal aberrations in UVB-induced tumors of immunosuppressed miceAmy M Dworkin, Kathleen L Tober, F Jason Duncan, et al.
Acta Neuropathologica Communications|December 4, 2023
Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differencesWesley Wang, Jonah Domingo Tugaoen, Paolo Fadda, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Familial Cancer|April 15, 2024
Clinical features of prostate cancer by polygenic risk scoreChristina Spears, Menglin Xu, Abigail Shoben, et al.
Cancer Research|January 28, 2010
Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombinationDerek J R Ransburgh, Natsuko Chiba, Chikashi Ishioka, et al.
Familial Cancer|April 3, 2009
Methylation not a frequent "second hit" in tumors with germline BRCA mutationsAmy M Dworkin, Andrew D Spearman, Stephanie Y Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceAndrew D Spearman, Kevin Sweet, Xiao-Ping Zhou, et al.
Journal of Genetic Counseling|March 8, 2019
Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM)Christopher Heinlen, Shelly R Hovick, Guy N Brock, et al.
Acta Neurochirurgica|January 4, 2022
Genetic analysis of a malignant meningioma and associated metastasesKristin Huntoon, Ayse Selen Yilmaz, Maciej Pietrzak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2014
Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcomaJessica A Hemminger, Amanda Ewart Toland, Thomas J Scharschmidt, et al.
Peerj|May 7, 2013
Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible miceJessica L Fleming, Dustin L Gable, Somayeh Samadzadeh-Tarighat, et al.
Genes, Chromosomes & Cancer|March 20, 2009
Chromosomal aberrations in UVB-induced tumors of immunosuppressed miceAmy M Dworkin, Kathleen L Tober, F Jason Duncan, et al.
Acta Neuropathologica Communications|December 4, 2023
Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differencesWesley Wang, Jonah Domingo Tugaoen, Paolo Fadda, et al.
Pageof 8